HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Estivill Selected Research

Neurofibromatosis 2 (Neurofibromatosis Type II)

1/2022CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Estivill Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 01/2022
1Neurilemmoma (Schwannoma)
01/2022
1Acoustic Neuroma (Acoustic Neurinoma)
01/2022
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2022
1Hearing Loss (Hearing Impairment)
01/2022

Drug/Important Bio-Agent (IBA)

2Histone Deacetylases (Histone Deacetylase)IBA
01/2022 - 01/2022
1Neurofibromin 2 (Merlin)IBA
01/2022
1fimepinostatIBA
01/2022
1Histone Deacetylase InhibitorsIBA
01/2022
1Protamine KinaseIBA
01/2022